Combination of IL-33 with PD-1 blockade augment mILC2s-mediated anti-tumor immunity

被引：0
作者：
Jiawei Yue
Hui Guo
Peng Xu
Jinhong Ma
Weifeng Shi
Yumin Wu
机构：
[1] The Third Affiliated Hospital of Soochow University,Department of Orthopaedics
[2] The Third Affiliated Hospital of Soochow University,Department of Laboratory Medicine
[3] Institute of Nano and Soft Materials (FUNSOM) College of Nano Science &Technology (CNST) Suzhou,Jiangsu Key Laboratory for Carbon
来源：
Cancer Immunology, Immunotherapy | / 73卷
关键词：
Group 2 innate lymphoid cells; Interleukin-33; Cancer immunotherapy; Mature ILC2; Programmed cell death protein-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 51 条
[1]  
Siegel RL(2022)Cancer statistics, 2022 CA Cancer J Clin 72 7-33
[2]  
Miller KD(2021)Phenotype, specificity and avidity of antitumour CD8(+) T cells in melanoma Nature 596 119-125
[3]  
Fuchs HE(2021)Tumor cells and the extracellular matrix dictate the pro-tumoral profile of macrophages in CRC Cancers 118 23-2205
[4]  
Jemal A(2021)Landscape of innate lymphoid cells in human head and neck cancer reveals divergent NK cell states in the tumor microenvironment Proc Natl Acad Sci U S A 51 2188-309
[5]  
Oliveira G(2021)Innate lymphoid cells and cancer: role in tumor progression and inhibition Eur J Immunol 44 301-259
[6]  
Coletta S(2021)Innate lymphoid cells in tissue homeostasis and disease pathogenesis Mol Cells 20 250-216.e218
[7]  
Moreno-Nieves UY(2022)Innate lymphoid cells and cancer Nat Immunol 12 201-2950
[8]  
Yuan X(2021)ILC1 drive intestinal epithelial and matrix remodelling Nat Mater 171 2939-688
[9]  
Rasul F(2021)Adiponectin restrains ILC2 activation by AMPK-mediated feedback inhibition of IL-33 signaling J Exp Med 210 671-48
[10]  
Nashan B(2021)ILC3, a central innate immune component of the gut-brain axis in multiple sclerosis Front Immunol 18 17-864
123456